Want to see IMNN full AI Analyst Report?
Imunon (IMNN) Stock Statistics & Valuation Metrics
Total Valuation
Imunon has a market cap or net worth of $5.11M. The enterprise value is $10.29M.
- Market Cap
- $5.11M
- Enterprise Value
- $10.29M
Share Statistics
Imunon has 5,611,403 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,611,403
- Owned by Insiders
- 6.54%
- Owned by Institutions
- 5.64%
Financial Efficiency
Imunon’s return on equity (ROE) is -2.05 and return on invested capital (ROIC) is -181.53%.
- Return on Equity (ROE)
- -2.05
- Return on Assets (ROA)
- -1.18
- Return on Invested Capital (ROIC)
- -181.53%
- Return on Capital Employed (ROCE)
- -1.91
- Revenue Per Employee
- 0
- Profits Per Employee
- -724.75K
- Employee Count
- 20
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Imunon is -0.20. Imunon’s PEG ratio is -0.00.
- PE Ratio
- -0.20
- PS Ratio
- 0.00
- PB Ratio
- 1.14
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Imunon had revenue of 0 and earned -14.49M in profits. Earnings per share was -6.83.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -14.65M
- Pretax Income
- -14.50M
- Net Income
- -14.49M
- EBITDA
- -13.80M
- Earnings Per Share (EPS)
- -6.83
Cash Flow
In the last 12 months, operating cash flow was -4.00B and capital expenditures -69.08M, giving a free cash flow of -4.07B billion.
- Operating Cash Flow
- -4.00B
- Free Cash Flow
- -4.07B
- Free Cash Flow per Share
- -778.17
Dividends & Yields
Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -79741.26%
- Earnings Yield
- -309.03%
Stock Price Statistics
- Beta
- -0.90
- 52-Week Price Change
- -79.73%
- 50-Day Moving Average
- 1.31
- 200-Day Moving Average
- 2.21
- Relative Strength Index (RSI)
- 36.16
- Average Volume (3m)
- 109.03K
Important Dates
Imunon upcoming earnings date is Nov 12, 2026, Before Open (Not Confirmed).
- Last Earnings Date
- Aug 11, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Imunon as a current ratio of 2.32, with Debt / Equity ratio of 14.27%
- Current Ratio
- 2.32
- Quick Ratio
- 2.32
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- 0.56
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Imunon has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Imunon EV to EBITDA ratio is -0.44, with an EV/FCF ratio of -0.00.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.44
- EV to Free Cash Flow
- -0.00
- EV to Operating Cash Flow
- -0.00
Balance Sheet
Imunon has $6.86M in cash and marketable securities with $7.85M in debt, giving a net cash position of -$980.91K billion.
- Cash & Marketable Securities
- $6.86M
- Total Debt
- $7.85M
- Net Cash
- -$980.91K
- Net Cash Per Share
- -$0.17
- Tangible Book Value Per Share
- $0.80
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Imunon is $15.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $15.67
- Price Target Upside
- 1621.61% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 71.67%
Scores
- Smart Score
- ―
- AI Score
- 46
